Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $40.0000 (0.98%) ($40.0000 - $40.0000) on Thu. Sep. 21, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.21% (three month average) | RSI | 39 | Latest Price | $40.0000(0.98%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.3% a day on average for past five trading days. | Weekly Trend | HALO declines -2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) SPLV(17%) HYG(72%) BNDX(54%) BND(22%) JNK(69%) | Factors Impacting HALO price | HALO will decline at least -1.105% in a week (0% probabilities). GDX(-72%) IWC(-65%) IPO(-59%) SIL(-54%) EWG(-47%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.105% (StdDev 2.21%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
Resistance Level | $40.6 | 5 Day Moving Average | $39.49(1.29%) | 10 Day Moving Average | $39.42(1.47%) | 20 Day Moving Average | $40.6(-1.48%) | To recent high | -9.2% | To recent low | 17.2% | Market Cap | $5.467b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |